Thalidomide exerts synergistic or additive effects when combined with other drugs. This study reports the toxicity and efficacy of the combination of thalidomide plus oral melphalan in 27 patients with advanced multiple myeloma. We found that this combination induces a high response rate and a long progression-free survival without significantly increasing thalidomide-related toxicity.
|Number of pages||2|
|Publication status||Published - Dec 2003|
- Multiple myeloma
ASJC Scopus subject areas